Dublin, Aug. 13, 2021 (GLOBE NEWSWIRE) -- The "Injectable Drug Delivery Devices Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

"Injectable Drug Delivery Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Injectable Drug Delivery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Injectable Drug Delivery Devices are defined as administration of a drug into patient's blood through a delivery device.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Reasons to Buy

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Injectable Drug Delivery Devices Overview

3 Products under Development
3.1 Injectable Drug Delivery Devices - Pipeline Products by Stage of Development
3.2 Injectable Drug Delivery Devices - Pipeline Products by Segment
3.3 Injectable Drug Delivery Devices - Pipeline Products by Territory
3.4 Injectable Drug Delivery Devices - Pipeline Products by Regulatory Path
3.5 Injectable Drug Delivery Devices - Pipeline Products by Estimated Approval Date
3.6 Injectable Drug Delivery Devices - Ongoing Clinical Trials

4 Injectable Drug Delivery Devices - Pipeline Products under Development by Companies
4.1 Injectable Drug Delivery Devices Companies - Pipeline Products by Stage of Development
4.2 Injectable Drug Delivery Devices - Pipeline Products by Stage of Development

5 Injectable Drug Delivery Devices Companies and Product Overview

6 Injectable Drug Delivery Devices- Recent Developments

7 Appendix

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/1u2u0o